By week three or four, most patients find their hunger returns to the well-controlled baseline they experienced on semaglutide, but with more robust metabolic support
Apply for a Free 30-Minute Preliminary Case Review to see if your symptom history aligns with our functional nutrition support programs
Victoza is FDA-approved for two indications: To improve blood sugar control in adults and children aged 10 and older with type 2 diabetes To reduce cardiovascular risk in adults with type 2 diabetes and heart disease Saxenda is FDA-approved for weight loss in the following populations: Adults with obesity (body mass index, or BMI, of 30 or higher) Adults with overweight (BMI of 27 or higher) and a weight-related health condition, such as high blood pressure or cholesterol Children aged 12 and older with obesity The FDA approved a generic version of Victoza , known simply as liraglutide , in late 2024
Others require the full 2.4 mg
Many people don't realise how much of their daily fluid intake comes from food rather than drinks
[1,2] Practical tip: If you are non-diabetic and using semaglutide for weight loss, routine low sugar is not expected
